Home/Filings/4/0001144204-17-000878
4//SEC Filing

PHARMATHENE, INC 4

Accession 0001144204-17-000878

$ALTCIK 0001326190operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:31 PM ET

Size

17.6 KB

Accession

0001144204-17-000878

Insider Transaction Report

Form 4
Period: 2017-01-04
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2017-01-04$2.59/sh+10,000$25,900145,004 total
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2017-01-04$2.47/sh+20,000$49,400165,004 total
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2017-01-04$3.11/sh+20,000$62,200185,004 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-01-0420,0000 total
    Exercise: $2.47From: 2009-08-05Exp: 2019-08-05Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-01-0420,0000 total
    Exercise: $2.20From: 2017-06-01Exp: 2026-05-31Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-01-0410,0000 total
    Exercise: $2.59From: 2009-03-09Exp: 2018-06-13Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2017-01-04$2.20/sh+20,000$44,000205,004 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-01-0420,0000 total
    Exercise: $3.11From: 2012-06-23Exp: 2021-06-23Common Stock (20,000 underlying)

Issuer

PHARMATHENE, INC

CIK 0001326190

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001326190

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:31 PM ET
Size
17.6 KB